561 related articles for article (PubMed ID: 12379167)
1. Vasodilatory edema: a common side effect of antihypertensive therapy.
Messerli FH
Curr Cardiol Rep; 2002 Nov; 4(6):479-82. PubMed ID: 12379167
[TBL] [Abstract][Full Text] [Related]
2. Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema.
Makani H; Bangalore S; Romero J; Wever-Pinzon O; Messerli FH
Am J Med; 2011 Feb; 124(2):128-35. PubMed ID: 21295192
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacokinetics of vasodilators. Part I.
Kirsten R; Nelson K; Kirsten D; Heintz B
Clin Pharmacokinet; 1998 Jun; 34(6):457-82. PubMed ID: 9646008
[TBL] [Abstract][Full Text] [Related]
4. Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension.
Messerli FH; Oparil S; Feng Z
Am J Cardiol; 2000 Dec; 86(11):1182-7. PubMed ID: 11090788
[TBL] [Abstract][Full Text] [Related]
5. Comparison of antihypertensive effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist and a diuretic in patients with hypertension not controlled by angiotensin receptor blocker monotherapy.
Stergiou GS; Makris T; Papavasiliou M; Efstathiou S; Manolis A
J Hypertens; 2005 Apr; 23(4):883-9. PubMed ID: 15775795
[TBL] [Abstract][Full Text] [Related]
6. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
Burnier M; Pruijm M; Wuerzner G
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
[TBL] [Abstract][Full Text] [Related]
7. Pilot study to evaluate a water displacement technique to compare effects of diuretics and ACE inhibitors to alleviate lower extremity edema due to dihydropyridine calcium antagonists.
Weir MR; Rosenberger C; Fink JC
Am J Hypertens; 2001 Sep; 14(9 Pt 1):963-8. PubMed ID: 11587165
[TBL] [Abstract][Full Text] [Related]
8. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
Cestário EDES; Fernandes LAB; Giollo-Júnior LT; Uyemura JRR; Matarucco CSS; Landim MIP; Cosenso-Martin LN; Tácito LHB; Moreno H; Vilela-Martin JF; Yugar-Toledo JC
Trials; 2018 Feb; 19(1):101. PubMed ID: 29433578
[TBL] [Abstract][Full Text] [Related]
9. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
Roberts ME; Epstein BJ
J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098
[TBL] [Abstract][Full Text] [Related]
10. Calcium channel blockers in the prevention of end stage renal disease: a review.
Derwa A; Peeters P; Vanholder R
Acta Clin Belg; 2004; 59(1):44-56. PubMed ID: 15065696
[TBL] [Abstract][Full Text] [Related]
11. "Pulse" treatment with high-dose angiotensin blocker reverses renal arteriolar hypertrophy and regresses hypertension.
Ishiguro K; Hayashi K; Sasamura H; Sakamaki Y; Itoh H
Hypertension; 2009 Jan; 53(1):83-9. PubMed ID: 19047581
[TBL] [Abstract][Full Text] [Related]
12. Mitigation of calcium channel blocker-related oedema in hypertension by antagonists of the renin-angiotensin system.
de la Sierra A
J Hum Hypertens; 2009 Aug; 23(8):503-11. PubMed ID: 19148104
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence.
Antza C; Stabouli S; Kotsis V
Vasc Health Risk Manag; 2016; 12():443-451. PubMed ID: 27895487
[TBL] [Abstract][Full Text] [Related]
14. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
15. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
Talbert RL
J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacological basis of antihypertensive drug therapy].
Kolck UW; Zaugg CE; Erne P
Praxis (Bern 1994); 2004 May; 93(20):847-56. PubMed ID: 15195836
[TBL] [Abstract][Full Text] [Related]
17. Factors involved in the antihypertensive action of calcium antagonists.
Garthoff B; Kazda S; Knorr A; Thomas G
Hypertension; 1983; 5(4 Pt 2):II34-8. PubMed ID: 6345375
[TBL] [Abstract][Full Text] [Related]
18. Comparative peripheral edema for dihydropyridines calcium channel blockers treatment: A systematic review and network meta-analysis.
Liang L; Kung JY; Mitchelmore B; Cave A; Banh HL
J Clin Hypertens (Greenwich); 2022 May; 24(5):536-554. PubMed ID: 35234349
[TBL] [Abstract][Full Text] [Related]
19. Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers.
Makarounas-Kirchmann K; Glover-Koudounas S; Ferrari P
Clin Ther; 2009 Aug; 31(8):1652-63. PubMed ID: 19808126
[TBL] [Abstract][Full Text] [Related]
20. Incidence of pedal edema formation with dihydropyridine calcium channel blockers: issues and practical significance.
Weir MR
J Clin Hypertens (Greenwich); 2003; 5(5):330-5. PubMed ID: 14564133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
